Share on StockTwits

Solazyme (NASDAQ:SZYM) General Counsel Paul T. Quinlan sold 6,000 shares of the company’s stock on the open market in a transaction dated Monday, July 21st. The shares were sold at an average price of $9.80, for a total transaction of $58,800.00. Following the completion of the sale, the general counsel now directly owns 86,875 shares in the company, valued at approximately $851,375. The sale was disclosed in a filing with the SEC, which is available at this link.

Separately, analysts at Morgan Stanley reiterated an “overweight” rating on shares of Solazyme in a research note on Friday, May 30th. They now have a $15.00 price target on the stock. One research analyst has rated the stock with a hold rating and one has given a buy rating to the company. Solazyme presently has an average rating of “Buy” and a consensus price target of $15.00.

Solazyme (NASDAQ:SZYM) traded up 4.58% on Tuesday, hitting $10.28. The stock had a trading volume of 731,546 shares. Solazyme has a 52 week low of $8.00 and a 52 week high of $15.00. The stock has a 50-day moving average of $10.95 and a 200-day moving average of $11.1. The company’s market cap is $781.0 million.

Solazyme (NASDAQ:SZYM) last announced its earnings results on Monday, May 5th. The company reported ($0.44) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.33) by $0.11. The company had revenue of $12.40 million for the quarter, compared to the consensus estimate of $14.63 million. During the same quarter in the previous year, the company posted ($0.43) earnings per share. The company’s revenue for the quarter was up 85.1% on a year-over-year basis. On average, analysts predict that Solazyme will post $-1.51 earnings per share for the current fiscal year.

Solazyme, Inc operates as a renewable oil production company. The Company fuels include microbial-derived jet fuels, bio-diesels, and renewable diesels.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.